Source comparison
Tesamorelin + Ipamorelin Blend: Reconstitution Comparison
5mg blend 2.0mg/mL 2.5mL 0.2mg 28 days at 2–8°C Standard protocol—balances concentration and dissolution time; most common in research settings 2.5mg/mL 2.0mL 0.25mg Higher concentration reduces injection volume but increases peptide precipitation risk if not
This comparison does not assign a generated winner or score.
- 5mg blend
- 2.0mg/mL
- 2.5mL
- 0.2mg
- 28 days at 2–8°C
- Standard protocol—balances concentration and dissolution time; most common in research settings
- 2.5mg/mL
- 2.0mL
- 0.25mg
- Higher concentration reduces injection volume but increases peptide precipitation risk if not fully dissolved
- 10mg blend
- 5.0mL
- Suitable for protocols requiring larger total volume; same per-dose concentration as 5mg blend
- 2mg blend
- 1.0mg/mL
- 0.1mg
- Lower concentration extends dissolution certainty; ideal for protocols with low per-session dosing requirements
- The comparison shows concentration-volume trade-offs across common vial sizes. Higher concentrations (2.5mg/mL) are preferred when injection volume must be minimised, but they require meticulous wall-injection technique to prevent incomplete dissolution. Lower concentrations (1.0mg/mL) sacrifice injection convenience for guaranteed solubility—a worthwhile trade when working with temperature-sensitive protocols or when peptide purity is uncertain.